USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plant
The US health regulator has pulled up Intas Pharmaceuticals for manufacturing lapses, including violation of current good manufacturing practice
Continue readingThe Number One Finance & Business Blog!
The US health regulator has pulled up Intas Pharmaceuticals for manufacturing lapses, including violation of current good manufacturing practice
Continue readingDr Reddy’s Laboratories on Wednesday said its unit has inked a licensing agreement with Coya Therapeutics Inc to develop
Continue reading